Skip to main content
. 2020 Dec 20;16(2):109–118. doi: 10.30699/IJP.2020.120392.2310

Fig. 3.

Effect of various concentrations (0.001-0.1 µM) of idarubicin on the cell viability of MCF-7, SK-BR-3, and SK-OV-3 cells

Fig. 3

*P-value<0.05 in comparison to the corresponding control group, ‡ P-value<0.05 in comparison to the MCF-7 cells treated with idarubicin at the same concentration, $ P-value<0.05 in comparison to the SK-BR-3 cells treated with idarubicin at the same concentration.